Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$13,397,715
+$550,265 QoQ
Shares Held
36,998
+1.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#458
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aviance Capital Partners, LLC holds $78,033,539 across 10 Drug Manufacturers - General names. AMGN ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
147,328 | $37,073,617 | |
| 2 | AMGN |
Amgen Inc
This page
|
36,998 | $13,397,715 | |
| 3 | JNJ |
Johnson & Johnson
|
36,810 | $9,348,635 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,110 | $5,411,135 | |
| 5 | PFE |
Pfizer Inc
|
159,351 | $3,837,172 | |
| 6 | LLY |
ELI LILLY & Co
|
3,181 | $3,815,387 | |
| 7 | NVO |
Novo Nordisk A S
|
49,981 | $2,396,089 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,102 | $1,849,717 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,397,715 | 36,998 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $12,847,450 | 36,514 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $12,103,923 | 36,980 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,429,430 | 33,414 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $9,176,795 | 32,867 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $10,168,680 | 32,639 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,354,033 | 32,052 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $10,257,233 | 31,834 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $9,932,473 | 31,789 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,954,942 | 31,496 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $6,793,239 | 23,586 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,480,341 | 24,112 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,327,147 | 23,994 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $5,452,187 | 22,553 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,957,725 | 22,684 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,135,964 | 22,786 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,739,690 | 23,591 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,633,922 | 23,298 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,238,651 | 23,286 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,866,707 | 22,886 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,295,225 | 21,724 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,256,360 | 21,126 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $4,993,862 | 21,720 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,495,955 | 21,624 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $4,999,760 | 21,198 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $4,105,079 | 20,249 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||